Kiora Pharmaceuticals' KIO-300 Suppresses Seizure Activity in Preclinical Epilepsy Model

Kiora Pharmaceuticals announced that its ion channel modulator KIO-300 significantly reduced seizure-associated electrophysiological activity in an ex...